These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 28553295)
81. Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment. Shrestha R; Karki P; Huedo-Medina TB; Copenhaver M J Assoc Nurses AIDS Care; 2017; 28(1):85-94. PubMed ID: 27769735 [TBL] [Abstract][Full Text] [Related]
82. The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis. Shrestha R; Weikum D; Copenhaver M; Altice FL AIDS Behav; 2017 Apr; 21(4):1070-1081. PubMed ID: 27544515 [TBL] [Abstract][Full Text] [Related]
83. Adapting an Evidence-Based HIV Prevention Intervention Targeting High-Risk Migrant Workers: The Process and Outcome of Formative Research. Shrestha R; Karki P; Pandey S; Copenhaver M Front Public Health; 2016; 4():61. PubMed ID: 27066474 [TBL] [Abstract][Full Text] [Related]
84. Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in Treatment. Huedo-Medina TB; Shrestha R; Copenhaver M AIDS Behav; 2016 Aug; 20(8):1646-57. PubMed ID: 27052845 [TBL] [Abstract][Full Text] [Related]
85. The Influence of Neurocognitive Impairment on HIV Risk Behaviors and Intervention Outcomes among High-Risk Substance Users: A Systematic Review. Shrestha R; Copenhaver M Front Public Health; 2016; 4():16. PubMed ID: 26904535 [TBL] [Abstract][Full Text] [Related]
86. Sex-Related Differences in Self-Reported Neurocognitive Impairment among High-Risk Cocaine Users in Methadone Maintenance Treatment Program. Shrestha R; Huedo-Medina TB; Copenhaver MM Subst Abuse; 2015; 9():17-24. PubMed ID: 25861219 [TBL] [Abstract][Full Text] [Related]
87. Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States. Meade CS; Towe SL; Skalski LM; Robertson KR Drug Alcohol Depend; 2015 Apr; 149():128-35. PubMed ID: 25697913 [TBL] [Abstract][Full Text] [Related]
88. Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease. Thaler NS; Sayegh P; Kim MS; Castellon SA; Hinkin CH Arch Clin Neuropsychol; 2015 Mar; 30(2):114-21. PubMed ID: 25589442 [TBL] [Abstract][Full Text] [Related]
89. Improving Outcome of Psychosocial Treatments by Enhancing Memory and Learning. Harvey AG; Lee J; Williams J; Hollon SD; Walker MP; Thompson MA; Smith R Perspect Psychol Sci; 2014 Mar; 9(2):161-79. PubMed ID: 25544856 [TBL] [Abstract][Full Text] [Related]
90. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. Auerbach JD; Kinsky S; Brown G; Charles V AIDS Patient Care STDS; 2015 Feb; 29(2):102-10. PubMed ID: 25513954 [TBL] [Abstract][Full Text] [Related]
91. Changes in neurocognition and adherence over six months in HIV-infected individuals with cocaine or heroin dependence. Anderson AM; Higgins MK; Ownby RL; Waldrop-Valverde D AIDS Care; 2015; 27(3):333-7. PubMed ID: 25484035 [TBL] [Abstract][Full Text] [Related]
92. Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches. Brown JL; Sales JM; DiClemente RJ Curr HIV/AIDS Rep; 2014 Dec; 11(4):363-75. PubMed ID: 25216985 [TBL] [Abstract][Full Text] [Related]
95. Working memory impairment in cannabis- and opioid-dependent adolescents. Vo HT; Schacht R; Mintzer M; Fishman M Subst Abus; 2014; 35(4):387-90. PubMed ID: 25148203 [TBL] [Abstract][Full Text] [Related]
96. Integrating antiretroviral therapy in methadone maintenance therapy clinics: service provider perceptions. Lin C; Cao X; Li L Int J Drug Policy; 2014 Nov; 25(6):1066-70. PubMed ID: 24939555 [TBL] [Abstract][Full Text] [Related]
97. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. Liu A; Cohen S; Follansbee S; Cohan D; Weber S; Sachdev D; Buchbinder S PLoS Med; 2014 Mar; 11(3):e1001613. PubMed ID: 24595035 [TBL] [Abstract][Full Text] [Related]
98. Prevention and treatment produced large decreases in HIV incidence in a model of people who inject drugs. Marshall BD; Friedman SR; Monteiro JF; Paczkowski M; Tempalski B; Pouget ER; Lurie MN; Galea S Health Aff (Millwood); 2014 Mar; 33(3):401-9. PubMed ID: 24590937 [TBL] [Abstract][Full Text] [Related]
99. Uptake of PrEP for HIV slow among MSM. Kirby T; Thornber-Dunwell M Lancet; 2014 Feb; 383(9915):399-400. PubMed ID: 24494225 [No Abstract] [Full Text] [Related]
100. The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial. Belzer ME; Naar-King S; Olson J; Sarr M; Thornton S; Kahana SY; Gaur AH; Clark LF; AIDS Behav; 2014 Apr; 18(4):686-96. PubMed ID: 24271347 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]